Press "Enter" to skip to content

New patent expiration for Bristol Myers drug SPRYCEL

3
Copyright © DrugPatentWatch. Originally published at New patent expiration for Bristol Myers drug SPRYCEL

Annual Drug Patent Expirations for SPRYCEL
Annual Drug Patent Expirations for SPRYCEL

Sprycel is a drug marketed by Bristol Myers Squibb and is included in one NDA. It is available from one supplier. There are five patents protecting this drug and three Paragraph IV challenges.

SPRYCEL drug price trends.

Drug patent litigation for SPRYCEL.

The generic ingredient in SPRYCEL is dasatinib. One supplier is listed for this compound. Additional details are available on the dasatinib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Bristol Myers drug SPRYCEL
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!